Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

The cost to taxpayers could be enormous.Sales growth of Zepbound in the U.S. has been constrained by rules that bar Medicare, ...

Doctors have long told how they are treating increasing numbers of Brits who end up in hospital after providing false ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

If you’ve been holding off on joining a weight loss program because you’re apprehensive about the cost, you’ll be glad to ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

CHICAGO As 2025 begins and millions of Americans start working to keep their New Year’s resolutions, Attorney General Kwame ...

According to that study, those who use GLP-1 dugs, such as Wegovy and Ozempic, cut their grocery spend by about 6% during the ...